Columbia Research Enhanced Value ETF
REVS
4 hedge funds and large institutions have $676K invested in Columbia Research Enhanced Value ETF in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
300% more funds holding
Funds holding: 1 → 4 (+3)
254% more capital invested
Capital invested by funds: $191K → $676K (+$485K)
125.48% more ownership
Funds ownership: 33.42% → 158.89% (+125%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$315K |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
+$283K |
| 3 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$147K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$7.34K |
Top Sellers
REVS Hedge Fund Activity: Q2 2021 in Review
4 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q2 2021, worth a combined $676K — up 254% from $191K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new REVS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $315K.
- 4 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q2 2021, up from 1 in Q1 2021.
- Funds reported $676K of Columbia Research Enhanced Value ETF stock for Q2 2021, up 254% quarter-over-quarter.
- 3 funds opened new Columbia Research Enhanced Value ETF positions in Q2 2021 and 0 closed out, a net change of +3 holders.
- The largest Columbia Research Enhanced Value ETF buyer in Q2 2021 was Envestnet Asset Management, an estimated $315K added.
Based on aggregated 13F filings for Q2 2021.